These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6948393)

  • 21. Effects of pentoxifylline on red blood cell deformability and blood viscosity under hyperosmolar conditions.
    Leonhardt H; Grigoleit HG
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Sep; 299(2):197-200. PubMed ID: 909613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concerning the influence of pentoxifylline on the erythrocyte and platelet membranes.
    Stefanovich V
    Naunyn Schmiedebergs Arch Pharmacol; 1977; 297 Suppl 1():S9. PubMed ID: 193056
    [No Abstract]   [Full Text] [Related]  

  • 23. [The effect of pentoxifylline and propentofylline on the membrane fluidity of red blood cells in uncontrolled insulin-dependent (type 1) diabetic patients].
    Roul C; Juhan-Vague I; Rahmani-Jourdheuil D; Mishal Z; Vague P
    Pathol Biol (Paris); 1988 Oct; 36(8 Pt 2):1081-3. PubMed ID: 3065700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of pentoxifylline on rat erythrocytes of different age.
    Kramer JJ; Swislocki NI
    Mech Ageing Dev; 1985 Nov; 32(2-3):283-98. PubMed ID: 3003467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro effects of pentoxifylline on hemoglobin affinity for oxygen and electrolytic equilibrium of human blood.
    Ferraresi I; Bozzini F; Torta D; Frigerio R; Bernasconi C; Agostoni A
    Ric Clin Lab; 1983; 13(4):459-65. PubMed ID: 6658304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increase in red cell filterability after incubation with oxpentifylline.
    Dormandy J; Ernst E; Flute P
    Curr Med Res Opin; 1981; 7(8):520-2. PubMed ID: 7307544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Failure of pentoxifylline or cilostazol to improve blood and plasma viscosity, fibrinogen, and erythrocyte deformability in claudication.
    Dawson DL; Zheng Q; Worthy SA; Charles B; Bradley DV
    Angiology; 2002; 53(5):509-20. PubMed ID: 12365857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Whole blood and red cell ATP content in patients with peripheral vascular disease: the effect of cigarette smoking and oxpentifylline.
    Maughan RJ; Broom J; Smith G; Leiper JB; Ah-See AK; Engeset J; Evan-Wong A; Davidson RJ
    Angiology; 1984 Oct; 35(10):628-32. PubMed ID: 6497047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of hexobendine and pentoxifylline on the viscosity of erythrocyte suspension].
    Winkler R; Moser M
    Wien Klin Wochenschr; 1983 Mar; 95(6):209-13. PubMed ID: 6880203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Results of clinical, laboratory and haemorheological investigations of the use of pentoxifylline in high doses.
    Antignani PL; Todini AR; Saliceti F; Pacino G; Bartolo M
    Pharmatherapeutica; 1987; 5(1):50-6. PubMed ID: 3602022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of pentoxifylline on filterability of normal red blood cells and their adhesiveness to cultured endothelial cells.
    Sowemimo-Coker SO; Turner P
    Eur J Clin Pharmacol; 1985; 29(1):55-9. PubMed ID: 2996906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Red cell filterability in diabetes.
    Isogai Y; Mochzuki K; Maeda T
    Scand J Clin Lab Invest Suppl; 1981; 156():171-3. PubMed ID: 6948379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pentoxifylline--a new drug for the treatment of intermittent claudication.
    Chopra HK; Chopra KL; Aggarwal KK; Parashar SK
    Indian Heart J; 1989; 41(2):127-33. PubMed ID: 2744799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of pentoxifylline with human erythrocytes. I. Interaction of xanthine derivatives with human erythrocyte ghosts.
    Sato Y; Miura T; Suzuki Y
    Chem Pharm Bull (Tokyo); 1990 Feb; 38(2):552-4. PubMed ID: 2337972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pentoxifylline treatment in patients with occlusive peripheral arterial disease. Circulatory changes and effects on prostaglandin synthesis.
    Poggesi L; Scarti L; Boddi M; Masotti G; Serneri GG
    Angiology; 1985 Sep; 36(9):628-37. PubMed ID: 3901827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pentoxifylline treatment for microangiopathic hemolytic anemia caused by mechanical heart valves.
    Geller S; Gelber R
    Md Med J; 1999; 48(4):173. PubMed ID: 10461440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New therapy for microangiopathic hemolytic anemia caused by cardiac valve prosthesis: a case report [correction of new therapy for cardiac valve prosthesis caused by microangiopathic hemolytic anemia: a case report].
    Jim RT
    Hawaii Med J; 1988 Jun; 47(6):285. PubMed ID: 3403249
    [No Abstract]   [Full Text] [Related]  

  • 38. Photoplethysmographic documentation of improved microcirculation after pentoxifylline therapy.
    Roeren T; LeVeen RF; Nugent L
    Angiology; 1988 Nov; 39(11):929-33. PubMed ID: 3177959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The effect of pentoxifylline on the Ca2+-induced potassium efflux and on the ATPase-activity of erythrocytes (author's transl)].
    Porsche E; Stefanovich V
    Arzneimittelforschung; 1981; 31(5):825-8. PubMed ID: 6268121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of pentoxifylline and prostaglandin E1 on cold blood perfusion studied by red blood cell deformability.
    Sakai A; Kikuchi Y; Ohshima N; Hori M
    Angiology; 1987 Jul; 38(7):514-9. PubMed ID: 3619124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.